Trials / Recruiting
RecruitingNCT06523127
Withholding of Life-sustaining Treatment and Quality of Life After Severe Acute Brain Injury: Qualitative Analysis and Ethical Issues
Withholding of Life-sustaining Treatment and Quality of Life After Severe Acute Brain Injury: Qualitative Analysis and Ethical Issues.
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 14 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Withdrawal of life-sustaining treatment affects 10-15% of ICU patients, including those with severe acute brain injury, whose care appears futile in terms of prognosis based on clinical and paraclinical data, expected quality of life, patient preferences, age, or reduced quality of life. There are few studies on withholding treatment compared with withdrawing treatment, and even fewer on survivors after a decision to withhold treatment. Quality of life is defined by WHO as "an individual's perception of his or her position in life in the context of the culture and value systems in which he or she lives and in relation to his or her goals, expectations, standards and concerns". The relationship between quality of life and neurological outcome after severe acute brain injury is controversial and therefore difficult to predict. That's why the investigators question the legitimacy of making decisions to withhold treatment from patients with severe acute brain injury based on their expected quality of life, when this prediction is uncertain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Recording data from the ICU stay and the post-ICU follow-up. | Record analysis of the post-ICU follow-up with the Interpretative Phenomenological Analysis |
Timeline
- Start date
- 2024-06-03
- Primary completion
- 2024-09-01
- Completion
- 2024-09-01
- First posted
- 2024-07-26
- Last updated
- 2024-07-26
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06523127. Inclusion in this directory is not an endorsement.